Target- |
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseWithdrawn |
First Approval Ctry. / Loc.US |
First Approval Date11 Jun 1992 |
100 Clinical Results associated with Cadema Corp.
0 Patents (Medical) associated with Cadema Corp.
100 Deals associated with Cadema Corp.
100 Translational Medicine associated with Cadema Corp.